108 related articles for article (PubMed ID: 31109820)
1. Potential normalization of an asthma mHealth intervention in community pharmacies: Applying a theory-based framework.
Kosse RC; Murray E; Bouvy ML; de Vries TW; Stevenson F; Koster ES
Res Social Adm Pharm; 2020 Feb; 16(2):195-201. PubMed ID: 31109820
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a mobile health intervention to support asthma self-management and adherence in the pharmacy.
Kosse RC; Bouvy ML; de Vries TW; Koster ES
Int J Clin Pharm; 2019 Apr; 41(2):452-459. PubMed ID: 31028598
[TBL] [Abstract][Full Text] [Related]
3. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
Trials; 2014 Dec; 15():488. PubMed ID: 25494702
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the integration of standards and guidelines in community pharmacy practices.
Hattingh HL; King MA; Smith NA
Pharm World Sci; 2009 Oct; 31(5):542-549. PubMed ID: 19579055
[TBL] [Abstract][Full Text] [Related]
5. Validation of a tool for reporting pharmacists' interventions in everyday community pharmacy.
Vo TH; Bardet JD; Charpiat B; Leyrissoux C; Gravoulet J; Allenet B; Conort O; Bedouch P
J Clin Pharm Ther; 2018 Apr; 43(2):240-248. PubMed ID: 29143347
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pharmacists' interventions in asthma management: A systematic review.
Crespo-Gonzalez C; Fernandez-Llimos F; Rotta I; Correr CJ; Benrimoj SI; Garcia-Cardenas V
J Am Pharm Assoc (2003); 2018; 58(2):210-219. PubMed ID: 29439927
[TBL] [Abstract][Full Text] [Related]
7. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.
Fraeyman J; Foulon V; Mehuys E; Boussery K; Saevels J; De Vriese C; Dalleur O; Housiaux M; Steurbaut S; Naegels M; De Meyer GR; De Loof H; Van Hal G; Van den Broucke S
Res Social Adm Pharm; 2017; 13(1):98-108. PubMed ID: 26975932
[TBL] [Abstract][Full Text] [Related]
9. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
[TBL] [Abstract][Full Text] [Related]
10. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
11. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
Aruru M; Truong HA; Clark S
Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
[TBL] [Abstract][Full Text] [Related]
12. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.
Nelissen HE; Cremers AL; Okwor TJ; Kool S; van Leth F; Brewster L; Makinde O; Gerrets R; Hendriks ME; Schultsz C; Osibogun A; Van't Hoog AH
BMC Health Serv Res; 2018 Dec; 18(1):934. PubMed ID: 30514376
[TBL] [Abstract][Full Text] [Related]
14. Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study.
Watkins K; Trevenen M; Murray K; Kendall PA; Schneider CR; Clifford R
BMJ Open; 2016 Aug; 6(8):e012369. PubMed ID: 27580836
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting.
Elaro A; Bosnic-Anticevich S; Kraus K; Farris KB; Shah S; Armour C; Patel MR
Int J Clin Pharm; 2017 Aug; 39(4):935-944. PubMed ID: 28497209
[TBL] [Abstract][Full Text] [Related]
17. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
Williams M; Peterson GM; Tenni PC; Bindoff IK
Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
[TBL] [Abstract][Full Text] [Related]
18. An electronic tool to aid community pharmacists in optimizing care for persons with diabetes.
Williams SP; Nunemacher C; Holland C; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S136-S140.e4. PubMed ID: 31248846
[TBL] [Abstract][Full Text] [Related]
19. Definition of professionalism and tools for assessing professionalism in pharmacy practice: a systemic review.
Dubbai H; Adelstein BA; Taylor S; Shulruf B
J Educ Eval Health Prof; 2019; 16():22. PubMed ID: 31430841
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
